Health Care/Hospital

CytoMed Therapeutics Limited Announces Collaboration with MD Anderson Cancer Center to Advance Allogeneic Off-the-Shelf Gamma Delta T Cells in Oncology

SINGAPORE, May 9, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited (Nasdaq: GDTC) ("CytoMed" or the "Company"), a biopharmaceutical company focused on harnessing its licensed proprietary technologies to create novel allogeneic cell-based immunotherapies for the treatment of human cancers, today ...

2023-05-09 22:07 2328

Ubie collaborates with Google's Android platform "Health Connect (Beta)" as a launch partner in Japan

NEW YORK, May 9, 2023 /PRNewswire/ -- Ubie, Inc. (US Headquarters: 1460 Broadway,New York, Suite 10003, NY 10036; Co-Representative Directors: Yoshinori Abe and Kota Kubo; hereinafter referred to as "Ubie") has partnered with Google's Android platform, "Health Connect (Beta)," as one of the six ...

2023-05-09 21:00 2017

CABIO showcases the new products and Ready-to-Market solutions at Vitafoods Europe 2023

GENEVA, May 9, 2023 /PRNewswire/ -- On May 9-11, 2023, CABIO Biotech (Wuhan) Co., Ltd (CABIO), a leading Chinese biotechnology company, participates in the three-day Vitafoods Europe held inGeneva, Switzerland. Vitafoods was founded in 1997 as the largest European exhibition of nutraceuticals, he...

2023-05-09 20:10 2192

Positive Phase 2 Topline Results Show Novavax's COVID-Influenza Combination, Stand-alone Influenza and High-dose COVID Vaccine Candidates Demonstrate Robust Immune Responses

* This Phase 2 trial is evaluating three vaccine candidates: COVID-Influenza Combination, stand-alone influenza and high-dose COVID * Preliminary topline immune responses for all three vaccine candidates were robust versus authorized comparators * For the stand-alone influenza vaccine candid...

2023-05-09 18:28 2525

Indonesia's National Hospital deploys AppSealing to Protect its Mobile Apps and Customers' PHI

SAN JOSE, Calif., May 9, 2023 /PRNewswire/ -- National Hospital Indonesia (NHI) today announced that it has deployedAppSealing , a mobile application security  platform, to pro...

2023-05-09 15:28 2137

The First International Conference On Single-Cell And Spatial Omics is held in Guangzhou, China: the Golden Age of Single Cell Analysis

GUANGZHOU, China, May 8, 2023 /PRNewswire/ -- On April 16th 2023, the first International Conference on Single-cell and Spatial Omics (TICSSO-1) has come to a grand conclusion. The conference brings together on site over 2,000 professionals from academia, research and development, investment and ...

2023-05-09 12:27 1609

3 in 5 people Have Side Job to Help Make Ends Meet - Herbalife Asia Pacific Survey

SINGAPORE, May 9, 2023 /PRNewswire/ -- Herbalife, a global health and wellness company and community, released the findings of its 2023 Asia Pacific Side Job Survey which showed that almost 3 in 5 (59%) respondents have a side job, and the top reason for doing so is to make ends meet (61%). Other...

2023-05-09 12:22 897

TCI won three prizes in the 2023 Green World Awards, revealing new technologies at Vitafoods Europe

TAIPEI, May 8, 2023 /PRNewswire/ -- Another good news from TCI! TCI won three prizes in Green World Awards organized by the Green Organisation, namely "Green World Champion for Upcycling Economy," "Global Gold Winner for Biodiversity," and "Global Silver Winner for Corporate Sustainability." Winn...

2023-05-09 10:36 1752

IND Application for Phase Ⅲ Registration Study of KN026 in Combination with Chemotherapy for the First-line Treatment of Breast Cancer Was Approved by CDE

SUZHOU, China, May 9, 2023 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. jointly announced that the IND application was approved in China for the pivotal trial of the anti-HER2 bispecific antibody KN026 combined with Docetaxel (albumin-binding), i...

2023-05-09 10:00 2396

Online Competition Platform PitPat Has Launched an Environmentally-themed Competition

HOUSTON, May 8, 2023 /PRNewswire/ -- The PitPat theme competition, which is usually held on major anniversaries, was designed to make users more environmentally aware. PitPat, an online competition platform based in Houston, announced that the Arbor Day Challenge will be held fromMay 6 to May 9....

2023-05-08 23:30 1845

Singlera Genomics Receives FDA Breakthrough Device Designation for PDACatch, a Liquid Biopsy Assay for Pancreatic Cancer Detection in High-Risk Individuals

SAN DIEGO, May 8, 2023 /PRNewswire/ -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, today announced that it had received Breakthrough Device Designation from the Food and Drug Administration (FDA) for its PDACatch assay, a nov...

2023-05-08 22:00 1526

CIVCO Radiotherapy and Qfix Showcase as One Company at ESTRO 2023

CORALVILLE, Iowa, May 8, 2023 /PRNewswire/ -- CIVCO Radiotherapy and Qfix, now together as one company, will exhibit their innovative and patented solutions during the annual ESTRO Congress inVienna, Austria, 12-16 May 2023. The company encourages attendees to visit booth #200 to experience many ...

2023-05-08 22:00 2247

EmeTerm Anti Fatigue & Car Sickness Wristband Wins the IF and IDA Design Awards

VANCOUVER, BC, May 8, 2023 /PRNewswire/ -- Improving the driving experience of drivers and passengers has been one of the directions of innovation in the automotive industry for many years. To address motion sickness and driving fatigue, automakers are working to develop a variety of technologies...

2023-05-08 21:00 1867

PharmAbcine to participate in "BIO International Convention 2023"

DAEJEON, South Korea, May 8, 2023 /PRNewswire/ -- PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of fully human antibody therapeutics, announced today that the company will participate in the upcoming BIO International Convention 2023. Details...

2023-05-08 20:00 1767

Biosion Presents Discovery and Development Data at PEGS for its Anti-CD40 Agonistic Antibody

NEWARK, Del. and NANJING, China, May 8, 2023 /PRNewswire/ -- Biosion USA, Inc. (Biosion), a global R&D biotechnology company, today announced the upcoming presentation of discovery and development data for BSI-038, an anti-CD40 agonistic antibody at the PEGS Boston conference to be held from May ...

2023-05-08 19:30 1520

Chance Pharmaceuticals and Acorda Therapeutics Announce Agreement to Provide INBRIJA® in Greater China

HANGZHOU, China, May 8, 2023 /PRNewswire/ -- Chance Pharmaceuticals and Acorda Therapeutics, Inc. today announced that they have entered into distribution and supply agreements to provide INBRIJA® in Greater China (Mainland China, Taiwan, Hong Kong, and Macao). INBRIJA is indicated in the United ...

2023-05-08 19:30 1472

Thai developer MQDC's 'The Aspen Tree' residential project moves to capture surging demand from over-50s for developments designed around their own generational needs

Offers special assistance to people not currently resident in Thailand as well as 1-year and 5-year trial residential packagesand almost US$ 70,000 in introductory benefits "Under The Aspen Tree's lifetime care concept, through a single, one-time home and services buying payment, residents are p...

2023-05-08 19:22 2488

Hummingbird Bioscience to Present Preclinical Proof of Concept for Potentially First-In-Class Antibody Targeting Autoimmune Diseases

* HMBD-011 is a potentially first-in-class anti-VH4-34 antibody developed for treatment of VH4-34+ antibody-driven pathogenesis in lupus and cold agglutinin disease * Data presented shows preclinical proof of concept for HMBD-011 clearance of VH4-34+ antibodies and effective inhibition of col...

2023-05-08 18:30 1952

Ascletis Announces China NMPA Approval of Conducting a Phase IIa Clinical Trial for ASC10 to Treat Respiratory Syncytial Virus Infection

--Respiratory syncytial virus (RSV) infection treatment remains huge unmet medical needs and there is no effective drug for treatment globally so far --Dosage of 800 mg ASC10, twice daily was selected to conduct a Phase IIa study in patients with RSV infection --Preclinical research showed that ...

2023-05-08 16:50 2418

MEDICAL IP Is Creating Medical Digital Twins in Virtual Spaces, Powered by NVIDIA Omniverse

* MEDIP PRO, a real-time digital twin implementation solution based on medical imaging, is now connected to NVIDIA Omniverse * Maximize medical data scalability by sharing and simulating medical-imaging-based digital twins without time and space limitations SEOUL, South Korea and SANTA CLARA,...

2023-05-08 16:00 1678
1 ... 155156157158159160161 ... 806